446 related articles for article (PubMed ID: 28826702)
1. Preoperative prognostic nutritional index is a significant predictor of survival in patients with localized upper tract urothelial carcinoma after radical nephroureterectomy.
Huang J; Yuan Y; Wang Y; Chen Y; Kong W; Xue W; Chen H; Zhang J; Huang Y
Urol Oncol; 2017 Dec; 35(12):671.e1-671.e9. PubMed ID: 28826702
[TBL] [Abstract][Full Text] [Related]
2. Preoperative serum pre-albumin as an independent prognostic indicator in patients with localized upper tract urothelial carcinoma after radical nephroureterectomy.
Huang J; Wang Y; Yuan Y; Chen Y; Kong W; Chen H; Zhang J; Huang Y
Oncotarget; 2017 May; 8(22):36772-36779. PubMed ID: 27906675
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
Obata J; Kikuchi E; Tanaka N; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakagawa K; Oya M
Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922
[TBL] [Abstract][Full Text] [Related]
4. Impact of the preoperative prognostic nutritional index on survival outcomes in upper tract urothelial carcinomas.
Xue W; Tan P; Xu H; Yang L; Wei Q
Cancer Med; 2019 Jun; 8(6):2971-2978. PubMed ID: 31070304
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and Prognostic Significance of Preoperative Prognostic Nutritional Index in Patients with Upper Urinary Tract Urothelial Carcinoma.
Liu J; Wu P; Lai S; Song X; Wang M; Wang X; Liu S; Hou H; Zhang Y; Wang J
Nutr Cancer; 2022; 74(8):2964-2974. PubMed ID: 35297733
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of plasma fibrinogen levels in patients with localized upper tract urothelial carcinoma.
Tanaka N; Kikuchi E; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakamura S; Oya M
BJU Int; 2013 May; 111(6):857-64. PubMed ID: 22757942
[TBL] [Abstract][Full Text] [Related]
8. Preoperative controlling nutritional status (CONUT) score as a novel predictive biomarker of survival in patients with localized urothelial carcinoma of the upper urinary tract treated with radical nephroureterectomy.
Ishihara H; Kondo T; Yoshida K; Omae K; Takagi T; Iizuka J; Tanabe K
Urol Oncol; 2017 Sep; 35(9):539.e9-539.e16. PubMed ID: 28499734
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of Albumin/Globulin Ratio in Patients with Upper Tract Urothelial Carcinoma Patients Treated with Radical Nephroureterectomy.
Fukushima H; Kobayashi M; Kawano K; Morimoto S
Anticancer Res; 2018 Apr; 38(4):2329-2334. PubMed ID: 29599356
[TBL] [Abstract][Full Text] [Related]
10. Preoperative predictive factors focused on inflammation-, nutrition-, and muscle-status in patients with upper urinary tract urothelial carcinoma undergoing nephroureterectomy.
Itami Y; Miyake M; Tatsumi Y; Gotoh D; Hori S; Morizawa Y; Iida K; Ohnishi K; Nakai Y; Inoue T; Anai S; Tanaka N; Shimada K; Hirao S; Fujimoto K
Int J Clin Oncol; 2019 May; 24(5):533-545. PubMed ID: 30604161
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Impact of Preoperative Albumin-Globulin Ratio on Oncologic Outcomes in Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy.
Xu H; Tan P; Ai J; Huang Y; Lin T; Yang L; Wei Q
Clin Genitourin Cancer; 2018 Oct; 16(5):e1059-e1068. PubMed ID: 29980449
[TBL] [Abstract][Full Text] [Related]
12. The preoperative serum cystatin-C as an independent prognostic factor for survival in upper tract urothelial carcinoma.
Tan P; Shi M; Chen J; Xu H; Xie N; Xu H; Jiang Y; Ai JZ; Liu LR; Yang L; Wei Q
Asian J Androl; 2019; 21(2):163-169. PubMed ID: 30416134
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of preoperative plasma fibrinogen level and platelet-to-lymphocyte ratio (F-PLR) in patients with localized upper tract urothelial carcinoma.
Huang J; Yuan Y; Wang Y; Zhang J; Kong W; Chen H; Chen Y; Huang Y
Oncotarget; 2017 May; 8(22):36761-36771. PubMed ID: 27901490
[TBL] [Abstract][Full Text] [Related]
14. Preoperative predictive model and nomogram for disease recurrence following radical nephroureterectomy for high grade upper tract urothelial carcinoma.
Freifeld Y; Ghandour R; Singla N; Woldu S; Clinton T; Kulangara R; Bagrodia A; Matin SF; Petros FG; Raman JD; Robyak H; Yan J; Zhu H; Rapoport L; Lotan Y; Margulis V
Urol Oncol; 2019 Oct; 37(10):758-764. PubMed ID: 31378586
[TBL] [Abstract][Full Text] [Related]
15. Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma.
Fritsche HM; Novara G; Burger M; Gupta A; Matsumoto K; Kassouf W; Sircar K; Zattoni F; Walton T; Tritschler S; Baba S; Bastian PJ; Martínez-Salamanca JI; Seitz C; Otto W; Wieland WF; Karakiewicz PI; Ficarra V; Hartmann A; Shariat SF
Urol Oncol; 2012 Sep; 30(5):666-72. PubMed ID: 20933445
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Lymphovascular Invasion in Node-Negative Upper Urinary Tract Urothelial Carcinoma Patients Undergoing Radical Nephroureterectomy.
Liu W; Zhou Z; Dong D; Sun L; Zhang G
Yonsei Med J; 2019 Feb; 60(2):174-181. PubMed ID: 30666839
[TBL] [Abstract][Full Text] [Related]
17. The predictive value of positive urine cytology for outcomes following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma: a multi-institutional study.
Tanaka N; Kikuchi E; Kanao K; Matsumoto K; Shirotake S; Kobayashi H; Miyazaki Y; Ide H; Obata J; Hoshino K; Hayakawa N; Kosaka T; Oyama M; Miyajima A; Momma T; Nakagawa K; Jinzaki M; Nakajima Y; Oya M
Urol Oncol; 2014 Jan; 32(1):48.e19-26. PubMed ID: 24055429
[TBL] [Abstract][Full Text] [Related]
18. Predictive and Prognostic Value of Preoperative Thrombocytosis in Upper Tract Urothelial Carcinoma.
Foerster B; Moschini M; Abufaraj M; Soria F; Gust KM; Rouprêt M; Karakiewicz PI; Briganti A; Rink M; Kluth L; Mathieu R; Margulis V; Lotan Y; Aziz A; John H; Shariat SF;
Clin Genitourin Cancer; 2017 Dec; 15(6):e1039-e1045. PubMed ID: 28694147
[TBL] [Abstract][Full Text] [Related]
19. Significance of preoperative butyrylcholinesterase level as an independent predictor of survival in patients with upper urinary tract urothelial carcinoma treated with nephroureterectomy.
Noro D; Koie T; Hashimoto Y; Tanaka T; Ohyama C; Tobisawa Y; Yoneyama T; Imai A; Hatakeyama S; Yamamoto H; Kitayama M; Hirota K
Jpn J Clin Oncol; 2018 Feb; 48(2):184-189. PubMed ID: 29177431
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study.
Nakagawa T; Komemushi Y; Kawai T; Otsuka M; Miyakawa J; Uemura Y; Kanatani A; Taguchi S; Naito A; Suzuki M; Nishimatsu H; Hirano Y; Tanaka Y; Matsumoto A; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
World J Urol; 2017 Oct; 35(10):1569-1575. PubMed ID: 28397000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
